We tested the hypothesis that amplified mRNA levels of the ERBB1 in MLC from DLBCL patients may be driven by the increased expression of specific TF that transcriptionally activate ERBB1 expression. This evidence concerns the gene TF and diffuse large B-cell lymphoma.